LAN NGUYEN: Open Payments
NPI 1427430628 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,566 in 21 payments from 8 companies in 2025. Trend: 2023 $976 · 2024 $239 · 2025 $1,566
Food & beverage: $1,566
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $453 |
| Amgen Inc. | 5 | $306 |
| AKEBIA THERAPEUTICS INC | 2 | $230 |
| NxStage Medical, Inc. | 2 | $208 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $174 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $87 |
| Novo Nordisk Inc | 1 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $35 |
Products named: LOKELMA, Vafseo, KRYSTEXXA, Kerendia, FARXIGA, TAVNEOS, LIBERTY SELECT CYCLER, NXSTAGE SYSTEM ONE.
Industry payments across NM — which companies pay providers there.
